David Taber to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications David Taber has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
0.513
-
Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation. Ann Pharmacother. 2008 Jan; 42(1):116-20.
Score: 0.264
-
Effect of Angiotensin II Inhibitors on Gastrointestinal Bleeding in Patients With Left?Ventricular Assist Devices. J Am Coll Cardiol. 2019 04 16; 73(14):1769-1778.
Score: 0.145
-
Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
Score: 0.104